Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGI-1067 in Type 2 Diabetes Mellitus (ANDES)
NCT00525577Phase 3Unknown
- Sponsor
- AtheroGenics, Inc.
- Start
- Aug 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of succinobucol in type 2 diabetes mellitus (T2DM), sponsored by AtheroGenics, Inc.. Status: unknown.
02
Drugs
succinobucol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00525577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525577.